$0.00
$0.00 (0.00%)
End-of-day quote: 05/11/2024
ASX:EXL
Elixinol Wellness Annual Report
| Year | Year | 2023 | 2022 | 2019 | 2018 | ||
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$8.27M | $7.06M | $30.71M | $32.45M | |
| GM % | Gross Margin % |
|
41.36% | 42.31% | 21.76% | 56.70% | |
| OM | Operating Margin |
|
-71.33% | -138.20% | -115.54% | 1.45% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.01 | $-0.03 | $-0.26 | $0.01 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
632.74m | 316.13m | 137.76m | 124.55m | |
| OCF | Operating Cash Flow |
|
$-2.76M | $-8.15M | $-51.07M | $-5.25M | |
| FCF | Free Cash Flow |
|
$-5.86M | $-8.16M | $-68.17M | $-10.08M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.01 | $-0.03 | $-0.47 | $-0.09 |
